share_log

成都圣诺科肽药物研究有限公司基本情况及2024年第一季度财务报表

Basic information and Q1 financial statements for Chengdu Shengnuoke Peptide Drug Research Co., Ltd. in 2024.

SZSI ·  Jun 13

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.